Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023722
Filing Date
2024-09-19
Accepted
2024-09-19 18:28:03
Documents
2
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 form3-09192024_100900.html 3  
1 form3-09192024_100900.xml 3 1748
2 ex24-09192024_100900.htm EX-24 4029
  Complete submission text file 0001415889-24-023722.txt   7343
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTE BIOSCINCES, INC. 3060 PEGASUS PARK DR., BLDG 6 DALLAS TX 75247
Business Address
Kapoor Shivpreet Singh (Reporting) CIK: 0002038311 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38052 | Film No.: 241311400